These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 10328762)

  • 1. Compounds capable of generating singlet oxygen represent a source of artifactual data in scintillation proximity assays measuring phosphopeptide binding to SH2 domains.
    Pai JJ; Kirkup MP; Frank EA; Pachter JA; Bryant RW
    Anal Biochem; 1999 May; 270(1):33-40. PubMed ID: 10328762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The utility of FK506-binding protein as a fusion partner in scintillation proximity assays: application to SH2 domains.
    Sonatore LM; Wisniewski D; Frank LJ; Cameron PM; Hermes JD; Marcy AI; Salowe SP
    Anal Biochem; 1996 Sep; 240(2):289-97. PubMed ID: 8811923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rapid identification of phosphopeptide ligands for SH2 domains. Screening of peptide libraries by fluorescence-activated bead sorting.
    Müller K; Gombert FO; Manning U; Grossmüller F; Graff P; Zaegel H; Zuber JF; Freuler F; Tschopp C; Baumann G
    J Biol Chem; 1996 Jul; 271(28):16500-5. PubMed ID: 8663178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of phosphopeptide ligands for the Src-homology 2 (SH2) domain of Grb2 by phage display.
    Gram H; Schmitz R; Zuber JF; Baumann G
    Eur J Biochem; 1997 Jun; 246(3):633-7. PubMed ID: 9219519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A screening method of SH2 domain ligands and blockers using a solid phase binding.
    Koh WS; Yoon SY; Lee EK; Lee EK; Kwon BM; Kim JW; Han MY
    Cancer Lett; 1997 Nov; 120(1):1-7. PubMed ID: 9570379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SH2 domains mediate the sequential phosphorylation of HS1 protein by p72syk and Src-related protein tyrosine kinases.
    Ruzzene M; Brunati AM; Marin O; Donella-Deana A; Pinna LA
    Biochemistry; 1996 Apr; 35(16):5327-32. PubMed ID: 8611520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of 3-aminobenzyloxycarbonyl as an N-terminal group conferring high affinity to the minimal phosphopeptide sequence recognized by the Grb2-SH2 domain.
    Furet P; Gay B; García-Echeverría C; Rahuel J; Fretz H; Schoepfer J; Caravatti G
    J Med Chem; 1997 Oct; 40(22):3551-6. PubMed ID: 9357522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structures of the SH2 domain of Grb2: highlight on the binding of a new high-affinity inhibitor.
    Nioche P; Liu WQ; Broutin I; Charbonnier F; Latreille MT; Vidal M; Roques B; Garbay C; Ducruix A
    J Mol Biol; 2002 Feb; 315(5):1167-77. PubMed ID: 11827484
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Structural basis for the high affinity of amino-aromatic SH2 phosphopeptide ligands.
    Rahuel J; García-Echeverría C; Furet P; Strauss A; Caravatti G; Fretz H; Schoepfer J; Gay B
    J Mol Biol; 1998 Jun; 279(4):1013-22. PubMed ID: 9642078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Potent inhibition of Grb2 SH2 domain binding by non-phosphate-containing ligands.
    Yao ZJ; King CR; Cao T; Kelley J; Milne GW; Voigt JH; Burke TR
    J Med Chem; 1999 Jan; 42(1):25-35. PubMed ID: 9888830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrocyclization in the design of Grb2 SH2 domain-binding ligands exhibiting high potency in whole-cell systems.
    Wei CQ; Gao Y; Lee K; Guo R; Li B; Zhang M; Yang D; Burke TR
    J Med Chem; 2003 Jan; 46(2):244-54. PubMed ID: 12519063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Src homology-2 domain binding assays by scintillation proximity and surface plasmon resonance.
    Mandine E; Gofflo D; Jean-Baptiste V; Sarubbi E; Touyer G; Deprez P; Lesuisse D
    J Mol Recognit; 2001; 14(4):254-60. PubMed ID: 11500972
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Scintillation proximity assay (SPA) technology to study biomolecular interactions.
    Cook N; Harris A; Hopkins A; Hughes K
    Curr Protoc Protein Sci; 2002 May; Chapter 19():Unit 19.8. PubMed ID: 18429228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tyrosine phosphorylation of Grb2 by Bcr/Abl and epidermal growth factor receptor: a novel regulatory mechanism for tyrosine kinase signaling.
    Li S; Couvillon AD; Brasher BB; Van Etten RA
    EMBO J; 2001 Dec; 20(23):6793-804. PubMed ID: 11726515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BASH, a novel signaling molecule preferentially expressed in B cells of the bursa of Fabricius.
    Goitsuka R; Fujimura Y; Mamada H; Umeda A; Morimura T; Uetsuka K; Doi K; Tsuji S; Kitamura D
    J Immunol; 1998 Dec; 161(11):5804-8. PubMed ID: 9834055
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibitory effects of rosmarinic acid on Lck SH2 domain binding to a synthetic phosphopeptide.
    Ahn SC; Oh WK; Kim BY; Kang DO; Kim MS; Heo GY; Ahn JS
    Planta Med; 2003 Jul; 69(7):642-6. PubMed ID: 12898421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery of potent and selective SH2 inhibitors of the tyrosine kinase ZAP-70.
    Vu CB; Corpuz EG; Merry TJ; Pradeepan SG; Bartlett C; Bohacek RS; Botfield MC; Eyermann CJ; Lynch BA; MacNeil IA; Ram MK; van Schravendijk MR; Violette S; Sawyer TK
    J Med Chem; 1999 Oct; 42(20):4088-98. PubMed ID: 10514279
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surface plasmon resonance thermodynamic and kinetic analysis as a strategic tool in drug design. Distinct ways for phosphopeptides to plug into Src- and Grb2 SH2 domains.
    de Mol NJ; Dekker FJ; Broutin I; Fischer MJ; Liskamp RM
    J Med Chem; 2005 Feb; 48(3):753-63. PubMed ID: 15689159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug.
    Oneyama C; Nakano H; Sharma SV
    Oncogene; 2002 Mar; 21(13):2037-50. PubMed ID: 11960376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterization of major ligands for Src homology 2 domains derived from protein tyrosine kinases, from the adaptor protein SHC and from GTPase-activating protein in Ramos B cells.
    Baumann G; Maier D; Freuler F; Tschopp C; Baudisch K; Wienands J
    Eur J Immunol; 1994 Aug; 24(8):1799-807. PubMed ID: 7519995
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.